Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation

Newly Diagnosed ◽

Mgmt Promoter ◽

Faculty Opinions recommendation of Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718058732.793486575 ◽

2013 ◽

Author(s):

Joachim Baehring ◽

Kevin Becker

Keyword(s):

Radiation Therapy ◽

Maintenance Therapy ◽

Newly Diagnosed ◽

Mgmt Promoter ◽

Enzastaurin (ENZ) before and concomitant with radiation therapy (RTX) followed by ENZ maintenance therapy in patients with newly diagnosed glioblastoma (GBM) without hypermethylation of the O6-methylguanyl DNA-methyltransferase (MGMT) promoter: A multicenter, open-label, uncontrolled phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.2007 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 2007-2007 ◽

Cited By ~ 1

Author(s):

W. Wick ◽

J. Steinbach ◽

S. E. Combs ◽

M. Platten ◽

C. Hartmann ◽

...

Keyword(s):

Radiation Therapy ◽

Maintenance Therapy ◽

Phase Ii ◽

Dna Methyltransferase ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Open Label ◽

Mgmt Promoter ◽

Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation—the NCT Neuro Master Match (N2M2) pilot study

Neuro-Oncology ◽

10.1093/neuonc/nox216 ◽

2017 ◽

Vol 20 (6) ◽

pp. 826-837 ◽

Cited By ~ 12

Author(s):

Elke Pfaff ◽

Tobias Kessler ◽

Gnana Prakash Balasubramanian ◽

Anne Berberich ◽

Daniel Schrimpf ◽

...

Keyword(s):

Pilot Study ◽

Real Time ◽

Molecular Profiling ◽

Newly Diagnosed ◽

Mgmt Promoter ◽

A Novel Recursive Partitioning Analysis Classification in Newly Diagnosed Glioblastoma Patients Treated With Radiation Therapy and Temozolomide: Highlighting the MGMT Promoter Methylation Status

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.805 ◽

2016 ◽

Vol 96 (2) ◽

pp. E85

Author(s):

C.W. Wee ◽

E. Kim ◽

I.H. Kim ◽

I.A. Kim

Keyword(s):

Radiation Therapy ◽

Promoter Methylation ◽

Recursive Partitioning ◽

Methylation Status ◽

Mgmt Promoter Methylation ◽

Newly Diagnosed ◽

Promoter Methylation Status ◽

Mgmt Promoter ◽

Newly Diagnosed Glioblastoma ◽

Mgmt Promoter Methylation Status

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-3153 ◽

2016 ◽

Vol 22 (19) ◽

pp. 4797-4806 ◽

Cited By ~ 52

Author(s):

Wolfgang Wick ◽

Thierry Gorlia ◽

Pierre Bady ◽

Michael Platten ◽

Martin J. van den Bent ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Newly Diagnosed ◽

Mgmt Promoter ◽

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2011.04.050 ◽

2011 ◽

Vol 2011 ◽

pp. 143-144

Author(s):

J. Uhm

Keyword(s):

Maintenance Therapy ◽

Phase I ◽

Newly Diagnosed ◽

Newly Diagnosed Glioblastoma ◽

Concomitant Radiotherapy

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Case Medical Research ◽

10.31525/ct1-nct04047706 ◽

2019 ◽

Author(s):

Keyword(s):

Radiation Therapy ◽

Newly Diagnosed ◽

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Case Medical Research ◽

10.31525/ct1-nct04019262 ◽

2019 ◽

Author(s):

Keyword(s):

Radiation Therapy ◽

Newly Diagnosed ◽

Short Course ◽

Faculty Opinions recommendation of The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12047960.13188059 ◽

2011 ◽

Author(s):

David Schiff ◽

Roger Abounader

Keyword(s):

Radiation Therapy ◽

Newly Diagnosed ◽

Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.05.010 ◽

2020 ◽

Vol 108 (3) ◽

pp. 716-724

Author(s):

Rifaquat Rahman ◽

Lorenzo Trippa ◽

Stephanie Alden ◽

Geoffrey Fell ◽

Taher Abbasi ◽

...

Keyword(s):

Radiation Therapy ◽

Computational Biology ◽

Newly Diagnosed ◽